Cargando…
Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
OBJECTIVES: Chronic thromboembolic pulmonary hypertension (CTEPH) is associated with thrombotic states including elevated coagulation factor VIII (FVIII). Pulmonary endarterectomy (PEA) is the main treatment for CTEPH, and efficient anticoagulation is essential to prevent thromboembolism recurrence...
Autores principales: | Myllylahti, Lasse, Ropponen, Jussi, Lax, Mikko, Lassila, Riitta, Nykänen, Antti I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998419/ https://www.ncbi.nlm.nih.gov/pubmed/36890726 http://dx.doi.org/10.1177/10760296231158369 |
Ejemplares similares
-
Long-term Outcomes and Predictors of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy
por: Sun, Shuai, et al.
Publicado: (2022) -
Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension
por: Jenkins, David, et al.
Publicado: (2017) -
Pulmonary endarterectomy for patients with chronic thromboembolic disease
por: Yıldızeli, Şehnaz Olgun, et al.
Publicado: (2018) -
Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy
por: Auger, William R., et al.
Publicado: (2012) -
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with active Crohn’s disease
por: Sugiyama, Kayo, et al.
Publicado: (2019)